HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity.
Navid F. et al, (2024), Nat rev rheumatol
XGRm: A Web Server for Interpreting Mouse Summary-level Genomic Data.
Wang S. et al, (2024), J mol biol, 436
A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation.
Bao C. et al, (2024), Cell rep methods
Priority index for critical Covid-19 identifies clinically actionable targets and drugs.
Zhang Z. et al, (2024), Commun biol, 7
Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.
Barton A. et al, (2022), Infect immun
Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis.
Vecellio M. et al, (2021), Arthritis rheumatol, 73, 980 - 990
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.
Nancy Z. et al, (2021), Front immunol, 12
Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1).
Chen L. et al, (2020), Mol cell proteomics, 19, 871 - 883
Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1).
Chen L. et al, (2020), Mol cell proteomics, 19, 871 - 883
From genome-wide association studies to rational drug target prioritisation in inflammatory arthritis
Fang H. et al, (2020), The lancet rheumatology, 2, e50 - e62
GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis.
Shi H. et al, (2020), Front immunol, 11
A genetics-led approach defines the drug target landscape of 30 immune-related traits.
Fang H. et al, (2019), Nat genet, 51, 1082 - 1091
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases.
Hammitzsch A. et al, (2018), Sci rep, 8
Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators.
Lagou V. et al, (2018), Cell rep, 25, 798 - 810.e6
Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
Giza M. et al, (2018), Clin exp immunol, 191, 11 - 18
Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis.
Al-Mossawi MH. et al, (2017), Nat commun, 8
A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.
Schwerd T. et al, (2017), J exp med, 214, 2547 - 2562
Deficiency of filaggrin regulates endogenous cysteine protease activity, leading to impaired skin barrier function.
Wang XW. et al, (2017), Clin exp dermatol, 42, 622 - 631